The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Feb 2015
Randomized Controlled Trial Multicenter Study Comparative StudyStandard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent chemoradiation for patients with inoperable stage III non-small-cell lung cancer. ⋯ National Cancer Institute and Bristol-Myers Squibb.